ACVDL Treatment for Patients With Newly Diagnosed Multiple Myeloma

NCT01481194 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Doxorubicin
DRUG: Bortezomib
DRUG: Lenalidomide
DRUG: Dexamethasone
DRUG: Cyclophosphamide

Sponsor

Vejle Hospital

Collaborators

[object Object]